Reduced expression of the oligosaccharyltransferase exacerbates protein hypoglycosylation in cells lacking the fully assembled oligosaccharide donor

Glycobiology

Volumn 25, Issue 7, 2015, Pages 774-783

  Shrimal, Shiteshu ^a   Gilmore, Reid ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

asparagine linked glycosylation; congenital disorders of glycosylation; lipid linked oligosaccharide; oligosaccharyltransferase

Indexed keywords

ASPARAGINE; DOLICHOL; OLIGOSACCHARIDE; OLIGOSACCHARYLTRANSFERASE; TRANSFERASE; UNCLASSIFIED DRUG; DOLICHYL-DIPHOSPHOOLIGOSACCHARIDE - PROTEIN GLYCOTRANSFERASE; GLYCOSYLTRANSFERASE; MEMBRANE PROTEIN; PROTEIN;

ANIMAL CELL; ARTICLE; CELL LINE; CHO CELL LINE; CONGENITAL DISORDER OF GLYCOSYLATION; CONTROLLED STUDY; DONOR; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; GLYCOSYLATION; METABOLISM;

CRICETULUS GRISEUS; MAMMALIA;

CELL LINE; GLYCOSYLATION; HEXOSYLTRANSFERASES; HUMANS; MEMBRANE PROTEINS; OLIGOSACCHARIDES; PROTEINS;

EID: 84936804322     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwv018     Document Type: Article

References (35)

1. Aebi M. 2013. N-linked protein glycosylation in the ER. Biochim Biophys Acta. 1833:2430-2437.
2. Aebi M, Hennet T. 2001. Congenital disorders of glycosylation: Genetic model systems lead the way. Trends Cell Biol. 11:136-141.
3. Burda P, Aebi M. 1999. The dolichol pathway of N-linked glycosylation. Biochim Biophys Acta. 1426:239-257.
4. Cacan R, Duvet S, Labiau O, Verbert A, Krag SS. 2001. Monoglucosylated oligomannosides are released during the degradation process of newly synthesized glycoproteins. J Biol Chem. 276:22307-22312.
5. Cherepanova NA, Shrimal S, Gilmore R. 2014. Oxidoreductase activity is necessary for N-glycosylation of cysteine-proximal acceptor sites in glycoproteins. J Cell Biol. 206:525-539.
6. Eklund EA, Newell JW, Sun L, Seo NS, Alper G, Willert J, Freeze HH. 2005. Molecular and clinical description of the first US patients with congenital disorder of glycosylation Ig. Mol Genet Metab. 84:25-31.
7. Foulquier F, Duvet S, Klein A, Mir AM, Chirat F, Cacan R. 2004. Endoplasmic reticulum-associated degradation of glycoproteins bearing Man5GlcNAc2 and Man9GlcNAc2 species in the MI8-5 CHO cell line. Eur J Biochem. 271:398-404.
8. Freeze HH, Aebi M. 2005. Altered glycan structures: The molecular basis of congenital disorders of glycosylation. Curr Opin Struct Biol. 15:490-498.
9. Haeuptle MA, Hennet T. 2009. Congenital disorders of glycosylation: An update on defects affecting the biosynthesis of dolichol-linked oligosaccharides. Hum Mutat. 30:1628-1641.
10. Imbach T, Grunewald S, Schenk B, Burda P, Schollen E,Wevers RA, Jaeken J, de Klerk JB, Berger EG, Matthijs G, et al. 2000. Multi-allelic origin of congenital disorder of glycosylation (CDG)-Ic. Hum Genet. 106:538-545.
11. Karaoglu D, Kelleher DJ, Gilmore R. 2001. Allosteric regulation provides a molecular mechanism for preferential utilization of the fully assembled dolichol-linked oligosaccharide by the yeast oligosaccharyltransferase. Biochemistry (Mosc). 40:12193-12206.
12. Kelleher DJ, Karaoglu D, Mandon EC, Gilmore R. 2003. Oligosaccharyltransferase isoforms that contain different catalytic STT3 subunits have distinct enzymatic properties. Mol Cell. 12:101-111.
13. Malaby HL, Kobertz WR. 2014. The middle x residue influences cotranslational N-glycosylation consensus site skipping. Biochemistry (Mosc). 53:4884-4893.
14. Marquardt T, Denecke J. 2003. Congenital disorders of glycosylation: Review of their molecular bases, clinical presentations and specific therapies. Eur J Pediatr. 162:359-379.
15. Molinari F, Foulquier F, Tarpey PS, Morelle W, Boissel S, Teague J, Edkins S, Futreal PA, Stratton MR, Turner G, et al. 2008. Oligosaccharyltransferasesubunit mutations in nonsyndromic mental retardation. Am J Hum Genet. 82:1150-1157.
16. Newell JW, Seo NS, Enns GM, McCraken M, Mantovani JF, Freeze HH. 2003. Congenital disorder of glycosylation Ic in patients of Indian origin. Mol Genet Metab. 79:221-228.
17. O'Rear JL, Scocca JR, Walker BK, Kaiden A, Krag SS. 1999. Chinese hamster ovary cells with reduced hexokinase activity maintain normal GDP-mannose levels. J Cell Biochem. 72:56-66.
18. Pearse BR, Gabriel L, Wang N, Hebert DN. 2008. A cell-based reglucosylation assay demonstrates the role of GT1 in the quality control of a maturing glycoprotein. J Cell Biol. 181:309-320.
19. Pearse BR, Tamura T, Sunryd JC, Grabowski GA, Kaufman RJ, Hebert DN. 2010. The role of UDP-Glc:glycoprotein glucosyltransferase 1 in the maturation of an obligate substrate prosaposin. J Cell Biol. 189:829-841.
20. Quellhorst GJJ, O'Rear JL, Cacan R, Verbert A, Krag SS. 1999. Nonglucosylated oligosaccharides are transferred to protein in MI8-5 Chinese hamster ovary cells. Glycobiology. 9:65-72.
21. Reiss G, te Heesen S, Zimmerman J, Robbins PW, Aebi M. 1996. Isolation of the ALG6 locus of Saccharomyces cerevisiae required for glucosylation in the N-linked glycosylation pathway. Glycobiology. 6:493-498.
22. Roboti P, High S. 2012a. Keratinocyte-associated protein 2 is a bona fide subunit of the mammalian oligosaccharyltransferase. J Cell Sci. 125: 220-232.
23. Roboti P, High S. 2012b. The oligosaccharyltransferase subunits OST48, DAD1 and KCP2 function as ubiquitous and selective modulators of mammalian N-glycosylation. J Cell Sci. 125:3474-3484.
24. Ruiz-Canada C, Kelleher DJ, Gilmore R. 2009. Cotranslational and posttranslational N-glycosylation of polypeptides by distinct mammalian OST isoforms. Cell. 136:272-283.
25. Schroder M, Kaufman RJ. 2005. ER stress and the unfolded protein response. Mutat Res. 569:29-63.
26. Shibatani T, David LL, McCormack AL, Frueh K, Skach WR. 2005. Proteomic analysis of mammalian oligosaccharyltransferase reveals multiple subcomplexes that contain Sec61, TRAP, and two potential new subunits. Biochemistry (Mosc). 44:5982-5992.
27. Shrimal S, Gilmore R. 2013. Glycosylation of closely spaced acceptor sites in human glycoproteins. J Cell Sci. 126:5513-5523.
28. Shrimal S, Ng BG, Losfeld ME, Gilmore R, Freeze HH. 2013. Mutations in STT3A and STT3B cause two congenital disorders of glycosylation. Hum Mol Genet. 22:4638-4645.
29. Shrimal S, Trueman SF, Gilmore R. 2013. Extreme C-terminal sites are posttranslocationally glycosylated by the STT3B isoform of the OST. J Cell Biol. 201:81-95.
30. Stagljar I, te Heesen S, Aebi M. 1994. New phenotype of mutations deficient in glucosylation of the lipid-linked oligosaccharide: Cloning of the ALG8 locus. Proc Natl Acad Sci USA. 91:5977-5981.
31. Trimble RB, Byrd JC, Maley F. 1980. Effect of glucosylation of lipid intermediates on oligosaccharide transfer in solubilized microsomes from Saccharomyces cerevisiae. J Biol Chem. 255:11892-11895.
32. Turco SJ, Stetson B, Robbins PW. 1977. Comparative rates of transfer of lipid-linked oligosaccharides to endogenous glycoprotein acceptors in vitro. Proc Natl Acad Sci USA. 74:4410-4414.
33. Westphal V, Kjaergaard S, Schollen E, Martens K, Grunewald S, Schwartz M, Matthijs G, Freeze HH. 2002. A frequent mild mutation in ALG6 may exacerbate the clinical severity of patients with congenital disorder of glycosylation Ia (CDG-Ia) caused by phosphomannomutase deficiency. Hum Mol Genet. 11:599-604.
34. Westphal V, Murch S, Kim S, Srikrishna G, Winchester B, Day R, Freeze HH. 2000. Reduced heparan sulfate accumulation in enterocytes contributes to protein-losing enteropathy in a congenital disorder of glycosylation. Am J Pathol. 157:1917-1925.
35. Zufferey R, Knauer R, Burda P, Stagljar I, te Heesen S, Lehle L, Aebi M. 1995. STT3, a highly conserved protein required for yeast oligosaccharyl transferase activity in vivo. EMBO J. 14:4949-4960.